FDA Inspection

Johnson and Johnson Innovative Medicine (previously Janssen Pharmaceuticals)December 13, 2024

FDA Inspection 1257802 - Johnson and Johnson Innovative Medicine (previously Janssen Pharmaceuticals) - December 13, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Johnson and Johnson Innovative Medicine (previously Janssen Pharmaceuticals), with an inspection on December 13, 2024, issued by the Philadelphia District Office, covering human drugs.

Company: Johnson and Johnson Innovative Medicine (previously Janssen Pharmaceuticals)
Inspection Date: December 13, 2024
Product Type: Human Drugs
Office: Philadelphia District Office

Open in Dashboard

ID · 73580ef6-dd7b-4b45-a406-291936eb7957